Core Viewpoint - The company Lianlong (300596.SZ) is accelerating its strategic investment in the high-end electronic adhesive market, marking a significant step in its domestic substitution strategy for electronic materials, particularly in the context of increasing demand for localized production in China [1][3]. Company Summary - Lianlong is a leading enterprise in the polymer materials sector, with its main business covering core areas such as aging-resistant additives and lubricant additives. Recently, the company has been expanding into high-value electronic-grade new materials [2]. - The company has made a strategic investment of 50 million yuan in Shenzhen Stofe New Materials Technology Co., Ltd., acquiring a 25% stake, which is a continuation of its efforts to enhance its electronic materials product matrix [1][2]. - The investment in Stofe is seen as a critical step in extending Lianlong's electronic materials product offerings and aligns with its strategy to penetrate the high-end adhesive market [2][3]. Industry Summary - The global electronic adhesive market is projected to grow from 5.1 billion USD in 2023 to 12.1 billion USD by 2033, with a compound annual growth rate (CAGR) of 9%. In China, the market is expected to exceed 17 billion yuan by 2025, with a growth rate of 12%-15% [3]. - Currently, the domestic market for electronic adhesives has a low localization rate of 20-30%, with high-end products accounting for less than 10%, indicating a significant opportunity for domestic substitution [3]. - Stofe, as a key player in the domestic electronic adhesive sector, has established multiple R&D centers and holds 87 patents, positioning itself to break foreign technology monopolies [4]. Strategic Implications - The investment is part of Lianlong's dual approach of "technology introduction + local cultivation" to advance the localization of electronic materials, focusing on high-end applications in flexible displays, semiconductor packaging, and new energy vehicles [5]. - The collaboration with Stofe aims to enhance production capacity for high-end products, addressing the urgent demand for domestic substitutes in the electronic adhesive market [4][6]. - The strategic investment reflects the company's commitment to supporting the domestic supply chain and addressing the challenges of high-end material dependency on foreign technologies [6].

Core Viewpoint - The company, Lianlong (300596), has announced a capital increase in Shenzhen Stof New Materials Technology Co., Ltd. by investing 50 million yuan, acquiring a 25% stake, which is part of its strategy to expand its electronic materials business into new product categories [1] Group 1: Investment Details - On November 26, the company signed a shareholder agreement and a capital increase agreement with Shenzhen Stof and Sun Siyuan [1] - The company will invest 50 million yuan, with 17.85714 million yuan allocated to the new registered capital and the remaining 48.214286 million yuan added to the capital reserve [1] Group 2: Strategic Expansion - This capital increase is aimed at expanding the company's electronic materials business, following its acquisition of Korean IPITECH INC. to enter the electronic-grade PI materials sector [1] - The new investment will facilitate the company's entry into core electronic-grade new materials used in flexible OLED displays, flexible printed circuits (FPC), chip packaging, and new energy vehicles [1]

Core Viewpoint - The company plans to invest 50 million RMB in Stodaf, acquiring a 25% stake, to expand its electronic materials business and enhance its product offerings in key sectors such as flexible OLED displays and electric vehicles [1] Group 1: Investment Details - The company will use its own funds of 50 million RMB to subscribe to Stodaf's newly registered capital of 1.785714 million RMB, with the remaining 48.214286 million RMB allocated to capital reserves [1] - After the investment, the company will hold a 25% equity stake in Stodaf [1] Group 2: Stodaf Overview - Stodaf is a leading domestic electronic adhesive manufacturer with four R&D centers located in Tianjin, Shenzhen, Shanghai, and Yokohama, Japan [1] - The company has formed a research team with over 40 university professors and holds 87 patents covering core resin systems such as epoxy, polyurethane, acrylic, and silicone [1] - Stodaf's innovative products, including anisotropic conductive adhesives and high-refractive-index nano-imprint adhesives, have successfully broken foreign technology monopolies and overcome technical barriers in the display industry, supplying over 300 leading clients in downstream industries [1] Group 3: Strategic Importance - The investment in Stodaf is part of the company's strategy to expand its electronic materials business, following its acquisition of Korean IPITECHINC. to enter the electronic-grade PI materials sector [1] - This move represents a significant step in the company's efforts to diversify into core electronic-grade new materials used in flexible OLED displays, flexible printed circuits (FPC), chip packaging, and new energy vehicles [1]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 49.50 CNY, based on an average P/E ratio of 18 times for comparable companies in 2026 [3][5]. Core Insights - The company's main business is gradually recovering after hitting a low point, leading to a slight downward adjustment in revenue and profit forecasts. The projected net profits for 2025, 2026, and 2027 are 542 million CNY, 631 million CNY, and 716 million CNY respectively [3][4]. - The company achieved a revenue of 4.509 billion CNY in the first three quarters of 2025, representing a year-on-year increase of 5.72%, with a net profit of 392 million CNY, up 24.92% year-on-year [9]. - The company is actively expanding into new business areas, including a partnership with Jima Gene for bioblock products and the acquisition of IPITECH INC. to enter the electronic-grade PI materials market [9]. Financial Performance Summary - Revenue projections for the years 2023 to 2027 are as follows: 5,278 million CNY (2023), 5,687 million CNY (2024), 6,297 million CNY (2025), 6,862 million CNY (2026), and 7,414 million CNY (2027), with respective growth rates of 9.0%, 7.7%, 10.7%, 9.0%, and 8.1% [4][11]. - The company's gross profit margin is expected to improve from 19.8% in 2023 to 24.0% in 2027, while the net profit margin is projected to increase from 6.9% to 9.7% over the same period [4][11]. - The earnings per share (EPS) are forecasted to rise from 1.58 CNY in 2023 to 3.12 CNY in 2027 [4][11].

Investment Rating - The investment rating for the company is "Outperform" (maintained) [1] Core Views - The company's performance met expectations, with stable growth in the anti-aging business and significant expansion in the lubricating oil additives segment [1][6] - The anti-aging agent business continues to expand, with a focus on increasing the proportion of high-end products and global market development [6] - The second phase of the Kangtai project is gradually releasing capacity, showing a clear trend of increasing volume and profit [6] - The life sciences business is moving towards market introduction, and the electronic-grade PI business is accelerating domestic and international integration [6] - The company has adjusted its profit forecasts for 2025-2027 due to competitive pressures, with expected net profits of 5.05 billion, 6.1 billion, and 7.15 billion respectively [6] Financial Data and Profit Forecast - Total revenue is projected to reach 6,095 million in 2025, with a year-on-year growth rate of 7.2% [2] - The net profit attributable to the parent company is expected to be 505 million in 2025, reflecting an 18.5% year-on-year growth [2] - Earnings per share are forecasted to be 2.20 yuan in 2025, with a gross margin of 21.9% [2] - The return on equity (ROE) is projected to be 10.4% in 2025 [2] Market Data - As of September 12, 2025, the closing price is 35.24 yuan, with a market capitalization of 7,860 million [3] - The price-to-book (PB) ratio is 1.8, indicating a relatively high safety margin compared to the historical average [3][6]

Investment Rating - The report maintains an "Outperform" rating for the company [2][7]. Core Views - The company's performance met expectations, with a focus on the anti-aging agent industry reaching a bottom and the upcoming increase in lubricant additive volume [1][2]. - The company is expanding its overseas market presence, with high-end products accounting for a growing share of sales, leading to an increase in revenue and profit margins [7]. - The second phase of the Kangtai project is gradually releasing capacity, contributing to performance growth, while the lubricant additive business is expected to benefit from global supply chain restructuring [7]. - The life sciences business is being pushed to market, with electronic-grade PI business accelerating integration domestically and internationally, opening new growth avenues [7]. - The profit forecast has been adjusted downwards for 2025-2026 due to trade disruptions and weak terminal demand, with new profit estimates for 2027 introduced [7]. Financial Data and Profit Forecast - Total revenue is projected to reach 6,559 million in 2025, with a year-on-year growth rate of 15.3% [3]. - Net profit attributable to the parent company is expected to be 585 million in 2025, reflecting a year-on-year growth of 37.2% [3]. - Earnings per share are forecasted to be 2.55 yuan in 2025, with a gross margin of 22.4% [3]. - The return on equity (ROE) is projected to be 11.8% in 2025, with a price-to-earnings (PE) ratio of 12 [3]. Market Data - As of May 20, 2025, the closing price of the stock is 29.92 yuan, with a market capitalization of 6,723 million [4]. - The stock has a price-to-book (PB) ratio of 1.5, indicating a relatively high safety margin compared to its historical average [4][7].